Ferrous Sulfate Versus Ferrous Fumarate Plus Zinc Sulfate and Vitamin C for Treatment of Iron Deficiency Anemia in Children
DOI:
https://doi.org/10.15379/2408-9877.2015.02.01.04Keywords:
Anemia, Iron deficiency, Ferrous sulfate, Ferrous fumarate, Children, Zinc, Vitamin C.Abstract
During childhood, different oral iron preparations are widely used in iron deficiency anemia (IDA) and prophylaxis. The purpose of this study was to compare the efficacy of different oral iron preparations in children with IDA. Eighty-nine children (age range, 1 to 17 years) with IDA were randomized to receive therapy orally in two divided doses of either 5 mg Fe2+/kg/day ferrous sulfate (FS group, n = 45) or ferrous fumarate plus zinc and vitamin C (FZ group, n = 44). Hematological profile and iron status were evaluated at the beginning and on days 15 and 45 of treatment. Mean Hb, mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), red cell distribution weight (RDW), and iron and ferritin levels were significantly higher in both groups on days 15 and 45 of treatment. Mean changes in Hb were 2.5 ± 1.2 g/dL and 2.1 ± 0.7 g/dL on day 15 (P = 0.295), and 3.9 ± 1.8 g/dL and 3.5 ± 1.2 g/dL on day 45 (P = 0.331) in the FS and FZ groups, respectively. Our study suggests that ferrous sulfate and ferrous fumarate plus zinc and vitamin C were well tolerated and were highly effective in correcting IDA in children. Ferrous fumarate plus zinc and vitamin C did not influence hematologic recovery compared with ferrous sulfate in this group.
References
Iron Deficiency Anaemia: Assessment, Prevention and Control. A Guide for Programme Managers, Geneva, World Health Organization.2001.
Jaber L, Rigler S, Taya A, et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy. J Pediatr Hematol Oncol. 2010; 32(8): 585-588.
Santiago P. Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview. ScientificWorldJournal 2012; 2012: 846-824.
Davidsson L, Kastenmayer P, Szajewska H, Hurrell RF, Barclay D. Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. Am J Clin Nutr 2000; 71(6): 1597-1602.
Sandstrom B, Davidsson L, Cederblad A, Lonnerdal B. Oral iron, dietary ligands and zinc absorption. J Nutr 1985; 115(3): 411-414.
Dijkhuizen MA, Wieringa FT, West CE, Martuti S, Muhilal S. Effects of iron and zinc supplementation in Indonesian infants on micronutrient status and growth. J Nutr 2001; 131(11): 2860-2865.
De Oliveira K de J, Donangelo CM, De Oliveira AV Jr, Da Silveira CL, Koury JC. Effect of zinc supplementation on the antioxidant, copper, and iron status of physically active adolescents. Cell Biochem Funct 2009; 27(3): 162-166.
Solomons NW. Competitive interaction of iron and zinc in the diet: consequences for human nutrition. J Nutr 1986; 116(6): 927-935.
Iannotti LL, Tielsch JM, Black MM, Black RE. Iron supplementation in early childhood: health benefits and risks. Am J Clin Nutr 2006; 84(6): 1261-1276.
Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr 2001 Jan; 73(1): 93-8.
Yewale VN, Dewan B. Treatment of iron deficiency anemia in children: a comparative study of ferrous ascorbate and colloidal iron. Indian J Pediatr 2013; 80(5): 385-90.
Teucher B, Olivares M, Cori H. Enhancers of iron absorption: ascorbic acid and other organic acids. Int J Vitam Nutr Res 2004; 74(6): 403-19.
Fischer Walker C1, Kordas K, Stoltzfus RJ, Black RE. Interactive effects of iron and zinc on biochemical and functional outcomes in supplementation trials. Am J Clin Nutr 2005; 82(1): 5-12.
Brugnara C. Oski FA, Nathan DG. Diagnostic Approach to the Anemic Patient. In: Nathan DG, Orkin SH, Gingsburg D, Look TA, eds. Nathan and Oski’s Hematology of Infancy and Childhood, 6th ed. Philadelphia: Saunders Elsevier; 2009: 456-463.
Lerner NB, Sills R. Iron-Deficiency Anemia. In: Kliegman RM, Stanton BF, St. Gemelli JW, Schor BF, Behrman RE. eds. Nelson Textbook of Pediatrics, 19th ed. Philadelphia: Elsevier Saunders, 2011; 1655-1658.
Aycicek A, Koc A, Oymak Y, Selek S, Kaya C, Guzel B. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia. J Pediatr Hematol Oncol 2014; 36(1): 57-61.
Arvas A, Gür E. Are ferric compounds useful in treatment of iron deficiency anemia? Turk J Pediatr 2000; 42(4): 352-3533.
Stotzfus RJ, Deryfuss ML. “Guidelines for the use of iron supplements to prevent and treat iron deficiency anaemia,” International Nutritional Anaemia Consultative Group ( INACG), World Health Organisation (WHO), United Nations Childrens Fund (UNICEF), Washington, DC, USA, 1998, http: //www.who.int/nutrition/publications/ micronutrients/guidelines for Iron supplementation.pdf.
Sözmen EY, Kavakli K, Cetinkaya B, Akçay YD, Yilmaz D, Aydinok Y. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia. Biol Trace Elem Res 2003; 94(1): 79-86.
Ece A, Uyanik BS, Iscan A, Ertan P, Yi?ito?lu MR. Increased serum copper and decreased serum zinc levels in children with iron defi ciency anemia. Biol Trace Element Res 1997; 59(1-3): 31-39.
Gürgöze MK, Olçücü A, Aygün AD, Taskin E, Kiliç M. Serum and hair levels of zinc, selenium, iron, and copper in children with iron-deficiency anemia. Biol Trace Elem Res Summer 2006; 111(1-3): 23-29.
Chang S, El Arifeen S, Bari S, et al. Supplementing iron and zinc: double blind, randomized evaluation of separate or combined delivery. Eur J Clin Nutr 2010; 64(2): 153-60.
Geltman PL, Meyers AF, Mehta SD, et al. Daily multivitamins with iron to prevent anemia in high-risk infants: a randomized clinical trial. Pediatrics 2004; 114(1): 86-93.
Reeves JD, Yip R. Lack of adverse side effects of oral ferrous sulfate therapy in 1-year-old infants. Pediatrics 1985; 75(2): 352-5.
Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002; 359(9307): 696-700.
Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 122-124.
Downloads
Published
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .